Home Press Releases Organoids and Spheroids Market Size Worth $1.99 Billion by 2027 | CAGR: 22.4%

Organoids and Spheroids Market Size Worth $1.99 Billion by 2027 | CAGR: 22.4% |

The global organoids and spheroids market expected to reach USD 1.99 billion by 2027 according to a new study by Polaris Market Research. The report “Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report, By Type (Organoids, Spheroids); By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity & Efficacy Testing); By End-Use; By Regions; Segment Forecast, 2020 – 2027 gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

 The global organoids and spheroids industry is anticipated to grow, owing to the growing incidence of cancer, innovations in the tissue culture system, and continually failing organ transplantation surgeries. The compatibility between the donor and recipient should be cross-checked through artificial cell culture systems to save time and money.

 

The global market industry is fragmented based on type, application, end-use, and region. In terms of type, the market is segmented into organoids and spheroids. The application segment is further divided into developmental biology, personalized medicine, regenerative medicine, disease pathology studies, and drug toxicity & efficacy testing. In terms of end-use, the market is segmented into biotechnology and pharmaceutical industries, academic & research institutes, and hospitals and diagnostic centers.

 

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link: https://www.polarismarketresearch.com/industry-analysis/organoids-and-spheroids-market/request-for-sample

 

Segment Highlights

  • The spheroids market segment accounted for a major revenue share owing to its applicability in cancer research. The segment held over 50.0% of the global share in 2019. However, the organoid segment is expected to witness the highest CAGR during the forecast period.
  • Based on the application, the development biology segment is projected to constitute almost half of the market in 2027. This is can be attributed for increased use of cell culture systems in developmental biology.
  • North American region is dominating the global organoids and spheroids industry, holding over one-third of the market share throughout the forecast period. The presence of key companies and increasing funding towards research are the factors responsible for its growth
  • The players operating in the market include 3D BioMatrix; Corning Incorporated, and Prellis Biologics and together held a significant market share of global organoids and spheroids industry in the year 2019.

List of Key Players

  • 3D BioMatrix
  • 3D Biotek LLC
  • AMS Biotechnology (Europe) Limited
  • Cellesce Ltd.
  • Corning Incorporated
  • Greiner Bio-One
  • Hubrecht Organoid Technology (HUB)
  • InSphero/Perkin Elmer
  • Prellis Biologics
  • Others

 

Polaris Market Research has segmented the organoids and spheroids market report on the basis of type, application, end-use, and region

 

Organoids and Spheroids, Type Outlook (Revenue – USD Million, 2016 – 2027)

  • By Type
    • Organoids
      • By Type
        • Neural
        • Hepatic
        • Intestinal
        • Other
      • By Method
        • General Submerged Method for Organoid Culture
        • Crypt Organoid Culture Techniques
        • Air Liquid Interface (ALI) Method for Organoid Culture
        • Clonal Organoids from Lgr5+ Cells
        • Brain and Retina Organoid Formation Protocol
      • By Source
        • Primary Tissues
        • Stem Cells
    • Spheroids
      • By Type
        • Multicellular tumor spheroids (MCTS)
        • Neurospheres
        • Mammospheres
        • Hepatospheres
        • Embryoid bodies
      • By Method
        • Micropatterned Plates
        • Low Cell Attachment Plates
        • Hanging Drop Method
        • Others
      • By Source
        • Cell Line
        • Primary Cell
        • iPSCs Derived Cells

Organoids and Spheroids, Application Outlook (Revenue – USD Million, 2016 – 2027)

  • Developmental Biology
  • Personalized Medicine
  • Regenerative Medicine
  • Disease Pathology Studies
  • Drug Toxicity & Efficacy Testing

Organoids and Spheroids, End-Use Outlook (Revenue – USD Million, 2016 – 2027)

  • Biotechnology & Pharmaceutical Industries
  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers

Organoids and Spheroids, Regional Outlook (Revenue – USD Million, 2016 – 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
  • Asia Pacific
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Indonesia
  • Central & South America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

License and Pricing

Buy Now

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing

Request For Customization

Please specify your research requirement and get customized report


Regional AnalysisSegmentation AnalysisIndustry OutlookCompetitive Analysis
By using this form you agree with the storage and handling of your data by this website.

Speak to Analyst

By using this form you agree with the storage and handling of your data by this website.